论文部分内容阅读
第五届全国放射性药物与标记化合物学术讨论会,经中国同位素公司、中国同位素学会、中国核化学与放射化学学会、中华医学会核医学学会共同筹备,于1992年10月26日在贵州省贵阳市召开。会议经过3天严肃、认真、热烈、紧张的交流与讨论,圆满地达到了预期的目的。出席这次会议的代表来自北京、上海、四川等地的科研院所、高等院校、生产单位及有关部门,共47人。会议共收到论文57篇,收录“论文摘要文集”的计53篇。其中~(99)Tc~m核素药物19篇,占35.8%;受体类药物11
The Fifth National Symposium on Radiopharmaceuticals and Labeled Compounds was co-prepared by China Isotope Corporation, China Isotope Society, China Society for Nuclear Chemistry and Radiochemistry, and Chinese Medical Association for Nuclear Medicine. On October 26, 1992, in Guiyang, Guizhou Province City held. After three days of serious, serious, enthusiastic and intense exchanges and discussions, the meeting met its goal satisfactorily. Delegates attending the meeting came from scientific research institutes, institutions of higher learning, production units and relevant departments in Beijing, Shanghai, Sichuan and other places, a total of 47 people. The conference received a total of 57 papers, including “Abstracts of Papers,” a total of 53 articles. Among them, 19 (99) Tc m nuclear drugs accounted for 35.8%, and receptor drugs 11